This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised for Breakouts

Durata Therapeutics

Another stock that's trending within range of triggering a near-term breakout trade is Durata Therapeutics (DRTX), a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. This stock is off to a decent start for the bulls in 2013, with shares up 12%.

If you take a look at the chart for Durata Therapeutics, you'll notice that this stock has started to bounce higher today right above its 50-day moving average at $7.99 a share with above-average volume. This bounce is quickly pushing shares of DRTX within range of triggering a near-term breakout trade.

>>4 Big Stocks to Trade (or Not)

Market players should now look for long-biased trades in DRTX if it manages to break out above some near-term overhead resistance levels at $9.05 to $9.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 31,302 shares. If that breakout triggers soon, then DRTX will set up to re-test or possibly take out its next major overhead resistance level at its all-time high of $10.63 a share. Any move above $10.63 would then push shares of DRTX into new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15 a share.

Traders can look to buy DRTX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $7.99 a share. One could also buy off strength once DRTX clears those breakout levels with volume and then simply use a stop that sits a few percentage points below your entry point.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ATOS $0.30 -6.20%
ANAC $56.84 -3.00%
DRTX $24.16 1.73%
JVA $3.65 1.39%
SAND $4.27 8.90%


Chart of I:DJI
DOW 17,652.50 -8.21 -0.05%
S&P 500 2,046.39 -4.24 -0.21%
NASDAQ 4,700.2180 -16.8760 -0.36%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs